The results of the study of memo - effectiveness and safety of the drug Mexidol®
- 00:00
Evidence -based medicine and its effectiveness
- 03:56
Chronic brain ischemia - classification and approaches to study
- 05:27
The main manifestations of chronic cerebrovascular pathology
- 06:03
Vascular and cognitive disorders: features and evidence
- 09:32
Recommendations for the treatment of chronic brain ischemia and the place of antioxidant therapy
- 12:38
The effectiveness of antioxidant drugs in the treatment of vascular diseases
- 14:25
Mexidol with brain ischemia: study of the effectiveness of the drug Mexidol® Forte
- 17:00
Mexidol in evidence-based medicine: the results of an international multicenter randomized double-blind-controlled study on assessing the effectiveness and safety of consecutive therapy with Mexidol® and Mexidol® Forte 250 in patients with chronic brain ischemia (memo)
- 19:04
The dynamics of the Montreal scale for assessing cognitive functions and the effect of the drug Mexidol®
- 22:15
The effectiveness of antioxidant therapy of chronic brain ischemia
- 25:19
Proven efficiency and safety of long and consistent therapy with Mexidol®
Zakharov Vladimir Vladimirovich - MD, professor at the Department of Nervous Diseases Faculty of Medicine of the First MGMU named after THEM. Sechenov
Announcement:
Medicine is an area that is constantly changing and developing. What was evidence 10 or 15 years ago may not be so relevant today. Requirements for confirmation of the effectiveness and safety of treatment methods, including pharmacotherapy, according to the principles of evidence -based medicine, become more and more strict. We need research that meet certain standards and are carried out on a large number of patients. The proof of the vascular nature of cognitive disorders, treatment protocols and drugs should be based on international-recognized criteria. Based on these criteria, the results of the study of the drug Mexidol® for the effectiveness of chronic brain ischemia are presented.
- 00:00
Evidence -based medicine and its effectiveness
- 03:56
Chronic brain ischemia - classification and approaches to study
- 05:27
The main manifestations of chronic cerebrovascular pathology
- 06:03
Vascular and cognitive disorders: features and evidence
- 09:32
Recommendations for the treatment of chronic brain ischemia and the place of antioxidant therapy
- 12:38
The effectiveness of antioxidant drugs in the treatment of vascular diseases
- 14:25
Mexidol with brain ischemia: study of the effectiveness of the drug Mexidol® Forte
- 17:00
Mexidol in evidence-based medicine: the results of an international multicenter randomized double-blind-controlled study on assessing the effectiveness and safety of consecutive therapy with Mexidol® and Mexidol® Forte 250 in patients with chronic brain ischemia (memo)
- 19:04
The dynamics of the Montreal scale for assessing cognitive functions and the effect of the drug Mexidol®
- 22:15
The effectiveness of antioxidant therapy of chronic brain ischemia
- 25:19
Proven efficiency and safety of long and consistent therapy with Mexidol®
Block of articles on this topic
Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.
Source of photos and images Shutterstock.com